The global AI medical imaging market, valued at US$ 1.29 billion in 2023, is forecasted to grow at a robust CAGR of 22.4%, ...

A new artificial intelligence-powered tool called MISO (Multi-modal Spatial Omics) can detect cell-level characteristics of cancer by looking at data from extremely small pieces of tissue—some as ...

The global AI medical imaging market, valued at US$ 1.29 billion in 2023, is forecasted to grow at a robust CAGR of 22.4%, reaching US$ 1.65 billion in 2024 and an impressive US$ 4.54 billion by 2029.

It marks one of the largest deals for the medical technology company since GE HealthCare was spun off from General Electric.

The global AI medical imaging market, valued at US$ 1.29 billion in 2023, is forecasted to grow at a robust CAGR of 22.4%, reaching US$ 1.65 ...

Aaron Hudy, GE HealthCare U.S. and Canada President, West Central Region, said his company’s technology can reduce patients’ ...

The model is the first of its kind to use multiple types of imaging and language-based data to assess a cancer patient's ...

Amazon Web Services and the venture capital firm General Catalyst launched a new multiyear agreement on Monday, marking their ...

IMVARIA has gained 510 (k) clearance from the US Food and Drug Administration (FDA) for its AI-powered healthcare tool, ...

The global C-arms market is seeing robust growth, driven by technological advancements and rising demand for minimally ...